About Helen Kim
Helen Kim is a director and 10% owner at Aktis Oncology.
Form D filings also name Helen Kim as a director at Recode Therapeutics and IconOVir Bio.
Helen Kim reports to the SEC as a director, officer or major shareholder of 9 public companies, including Prothena Corp. Public Ltd. (PRTA), Applied Molecular Transport (AMTI) and Assembly Biosciences (ASMB).
Helen Kim first appears on SEC filings in 2008.
Experience
This experience comes from SEC filings. The years are when the filings name Helen Kim in the role, so the role may have started earlier or lasted longer.
PC
Prothena Corp. Public Ltd. Co.
Director
2022 – 2025 · Public company (PRTA)
AI
Applied Molecular Transport Inc.
Director
2020 – 2021 · Public company (AMTI)
AI
Assembly Biosciences, Inc.
Director
2018 – 2020 · Public company (ASMB)
EI
Exicure, Inc.
Director
2017 – 2020 · Public company (XCUR)
KI
Kite Pharma, Inc.
EVP, Business Development
2015 – 2017 · Public company (KITE)
VI
Viracta Therapeutics, Inc.
Director
2009 – 2015 · Public company (VIRX)
IL
ImmunoCellular Therapeutics, Ltd.
Director
2012 – 2014 · Public company (IMUC)
KI
Kosan Biosciences Inc.
President and CEO
2008 · Public company (KOSN)
Key Colleagues at Startups
The people Helen Kim works with at each company, as listed on that company's latest Form D.
Recode Therapeutics, Inc. · Form D, Oct 23, 2025
RH
Rana Al-Hallaq
Director
PM
Patricia Millican
Director
SS
Shehnaaz Suliman
Executive officer and director
EH
Edward Hurwitz
Director
AC
Alan Colowick
Director
DL
David Lockhart
Executive officer
DM
Dean Mitchell
Director
BZ
Basheer Zada
Director
IP
Inai Park
Director
PT
Peter Thompson
Director
Rakhshita Dhar
Director
Aktis Oncology, Inc. · Form D, Oct 2, 2024
SB
Shulamit Ron-Bigger
Executive officer
KH
Ken Herrmann
Director
LS
Lloyd Segal
Director
ON
Oleg Nodelman
Director
AL
Andrew Levin
Director
MR
Matthew Roden
CEO and director
TF
Todd Foley
Director
IconOVir Bio, Inc. · Form D/A, Jun 4, 2024
SA
Sean Algeo
Executive officer and promoter
NL
Nicole van de Leuv
Executive officer
HN
Heba Nowyhed
Executive officer
DC
David Chang
Director and promoter
WK
William Kaelin
Director
JL
Jakob Loven
Director
JK
Joshua Kazam
Director and promoter
JM
Julie Maltzman
Executive officer
MM
Mark McCamish
Executive officer and director
JH
John Huynh
Executive officer
DT
David Tanen
Secretary